Design and development of 1,3,5-triazine-thiadiazole hybrids as potent adenosine A2A receptor (A2AR) antagonist for benefit in Parkinson's Disease

Publication date: Available online 30 June 2020Source: Neuroscience LettersAuthor(s): Anoop Masih, Saumya Singh, Amol Kumar Agnihotri, Sabeena Giri, Jitendra Kumar Shrivastava, Nidhi Pandey, Hans Raj Bhat, Udaya Pratap Singh
Source: Neuroscience Letters - Category: Neuroscience Source Type: research